Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 3Vitamin D Deficiency 1Stroke 1Spinal Cord Injuries 1Seizures 1Neurofibromatosis 1 1Meningitis 1Intracranial Hemorrhages 1Intracranial Aneurysm 1Glioblastoma 1Critical Illness 1Craniocerebral Trauma 1

Interventions

ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Topotecan 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Music Therapy 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1Gemcitabine 1Fosfomycin 1Dialectical Behavior Therapy 1Clozapine 1Ciprofloxacin 1Cidofovir 1Cholecalciferol 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningitis × Cholecalciferol × CNS × Clear all
NCT02881957 2022-06-15

Hypovitaminosis D in Neurocritical Patients

University of Utah

Phase 2/3 Completed
274 enrolled 16 charts
CNS

Brain Neoplasms, Intracranial Aneurysm, Craniocerebral Trauma, Meningitis, Seizures, Spinal Cord Injuries, Vitamin D Deficiency, Critical Illness, Intracranial Hemorrhages, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡